Literature DB >> 414759

Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.

E Ginzler, H Diamond, D Kaplan, M Weiner, M Schlesinger, M Seleznick.   

Abstract

Data from a prospective study of the clinical course in 223 patients with systemic lupus erythematosus followed for 655 patient-years were analyzed by computer to determine the influence on frequency of infection of 1) corticosteroid dose; 2) azathioprine; 3) active disease, measured by new disease exacerbations, elevated ESR, hypocomplementemia, active urinary sediment, and proteinuria; 4) uremia; and 5) leukopenia. The frequency of all infections, and of bacterial and opportunistic infections specifically, increased progressively with increasing steroid dose. Azathioprine use, independent of steroid dose, did not account for an increased risk of bacterial, opportunistic, or nonspecific viral infections. Leukopenia did not predispose to infection, except possibly when associated with azathioprine-induced bone marrow suppression. Active renal disease, especially when manifested by abnormal urine sediment, was associated with an increase in infection frequency.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 414759     DOI: 10.1002/art.1780210107

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  52 in total

Review 1.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

2.  Prophylactic use of antibiotics and immunisations in patients with SLE.

Authors:  W R Gilliland; G C Tsokos
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

3.  Successful therapy of meningococcal sepsis in acute disseminated lupus erythematosus with plasmapheresis, immunosuppression, and antibiotics.

Authors:  G J Dobos; S Meske; E Keller; W Riegel; P Vaith; H H Peter; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1990-10-03

Review 4.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

5.  Clinical benefits of methylprednisolone in off-pump coronary artery bypass surgery.

Authors:  Takanori Suezawa; Atsushi Aoki; Mitsuhisa Kotani; Mamoru Tago; Osamu Kobayashi; Akihito Hirasaki; Minako Sano; Nana Kameda; Hiroki Mitsunaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-05

Review 6.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus.

Authors:  S H Boghossian; D A Isenberg; G Wright; M L Snaith; A W Segal
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

8.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

Review 9.  Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Authors:  Johanna Westra; Christien Rondaan; Sander van Assen; Marc Bijl
Journal:  Nat Rev Rheumatol       Date:  2014-12-09       Impact factor: 20.543

Review 10.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.